Profiel
Anton Hoos currently works at Cy Biopharma AG, as Chief Executive Officer and Patient Focused Medicine Development, as Director from 2014.
Dr. Hoos also formerly worked at CSL Behring GmbH, as Vice President and Swedish Orphan Biovitrum AB, as Chief Medical Officer, Head-Medical Affairs, R&D in 2023.
Dr. Hoos received his Masters Business Admin degree from the University of Toronto and doctorate degree from Ludwig-Maximilians-Universität München.
Actieve functies van Anton Hoos
| Bedrijven | Functie | Begin |
|---|---|---|
Patient Focused Medicine Development | Directeur/Bestuurslid | 01-01-2014 |
Cy Biopharma AG
Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics | Algemeen Directeur | - |
Eerdere bekende functies van Anton Hoos
| Bedrijven | Functie | Einde |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Hoofd Techniek/Wetenschap/O&O | 19-06-2023 |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Corporate Officer/Principal | - |
Opleiding van Anton Hoos
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Patient Focused Medicine Development | |
Cy Biopharma AG
Cy Biopharma AG Miscellaneous Commercial ServicesCommercial Services Operates as a biotech platform generating novel psychedelic molecules for breakthrough therapeutics | Commercial Services |
















